Last updated on May 2019

A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atrial Fibrillation
  • Age: Between 40 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Inpatient hospitalization
  • Primary or secondary discharge International Classification of Diseases (ICD)-9/10 diagnosis code for AF paroxysmal (I48.0), persistent (I48.1), chronic (I48.2), or unspecified (427.31, I48.91)
  • Proxied Congestive Heart failure (CHA2DS2-VASC) score greater than or equal to (>=) 2 using ICD-9 diagnosis scoring algorithm developed previously. The scoring algorithm will be expanded to include ICD-10 codes
  • Discharged to home, skilled nursing facility, inpatient rehabilitation, or nursing home

Exclusion Criteria:

  • Presence of artificial mechanical heart valve by ICD-9/10 diagnosis or procedure code during comorbid identification period or current hospitalization
  • Surgical procedure during hospitalization for open heart surgery, brain, or spine
  • Intravenous heparin given on the day of discharge without warfarin/oral anticoagulant (OAC), antiplatelets, and/or aspirin
  • History of left atrial appendage occlusion, including the Watchman device
  • Any in-hospital (current hospitalization) bleeding identified by ICD-9/10 diagnosis codes

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.